Viewing Study NCT00968812

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-05-02 @ 8:35 PM
Study NCT ID: NCT00968812
Status: COMPLETED
Last Update Posted: 2017-01-30
First Post: 2009-08-28
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes View
None Metformin View
None Glimepiride View
None Hemoglobin A1c View
None Type 2 diabetes mellitus View
None Canagliflozin View